Swedish Agency Accused of Ignoring Research Fraud on 'Imid Drugs'

The Swedish Medical Products Agency is accused of overlooking research fraud related to 'imid drugs,' which are reported to increase the risk of premature death in elderly patients. Critics claim the agency is failing to investigate and address these issues, misleading both patients and doctors.